These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17125935)

  • 1. Could diabetic retinopathy be an autoimmune disease?
    Kastelan S; Zjacić-Rotkvić V; Kastelan Z
    Med Hypotheses; 2007; 68(5):1016-8. PubMed ID: 17125935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of anti-pericyte antibodies in the development of diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Klin Oczna; 2005; 107(7-9):541-3. PubMed ID: 16417018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
    Gustavsson C; Agardh E; Bengtsson B; Agardh CD
    J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
    Liinamaa MJ; Savolainen MJ
    Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of transforming growth factor-beta in the pathogenesis of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2006; 63(5):296-8. PubMed ID: 17036509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.
    Kakehashi A; Inoda S; Mameuda C; Kuroki M; Jono T; Nagai R; Horiuchi S; Kawakami M; Kanazawa Y
    Diabetes Res Clin Pract; 2008 Mar; 79(3):438-45. PubMed ID: 18053608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II antigen expression in diabetic preretinal membranes.
    Baudouin C; Gordon WC; Fredj-Reygrobellet D; Baudouin F; Peyman G; Gastaud P; Bazan NG
    Am J Ophthalmol; 1990 Jan; 109(1):70-4. PubMed ID: 1688686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating antipericyte autoantibodies in diabetic retinopathy.
    Attawia MA; Nayak RC
    Retina; 1999; 19(5):390-400. PubMed ID: 10546933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of diabetic retinopathy].
    Pelikánová T
    Vnitr Lek; 2007 May; 53(5):498-505. PubMed ID: 17642432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to types II and IV collagens, tumor necrosis factor-alpha and circulating immune complexes in lacrimal fluid and serum of patients with diabetic retinopathy and different stages].
    Balashova LM; Zaĭtseva NS; Teplinskaia LE; Koval'chuk LV; Gankovskaia LV; Obraztsova EN; Aronskind MS
    Vestn Oftalmol; 2000; 116(3):31-4. PubMed ID: 10918849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macrophages and HLA-DR expression in proliferative vitreoretinopathy].
    Scheiffarth OF; Tang S; Kampik A
    Fortschr Ophthalmol; 1990; 87(4):340-3. PubMed ID: 2210559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Manifestations of immunopathology and validation of immunotherapy of diabetic retinopathy].
    Zaĭtseva NS; Dudnikova LK; Slepova OS; Li LS; Smirnova NB; Zueva MV; Kalamkarov GR; Shevchenko TF
    Vestn Oftalmol; 1997; 113(1):27-31. PubMed ID: 9133040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraretinal leakage and oxidation of LDL in diabetic retinopathy.
    Wu M; Chen Y; Wilson K; Chirindel A; Ihnat MA; Yu Y; Boulton ME; Szweda LI; Ma JX; Lyons TJ
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2679-85. PubMed ID: 18362112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of local factors in the pathogenesis of diabetic retinopathy].
    Nesterov AP
    Vestn Oftalmol; 1994; 110(4):7-9. PubMed ID: 7871656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
    Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
    Saverino D; Brizzolara R; Simone R; Chiappori A; Milintenda-Floriani F; Pesce G; Bagnasco M
    Clin Immunol; 2007 May; 123(2):190-8. PubMed ID: 17321799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retinal vascular lesions in diabetic retinopathy].
    Crăiţoiu S; Mocanu C; Olaru C; Rodica M
    Oftalmologia; 2005; 49(1):82-7. PubMed ID: 15934345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.